I have been playing the first 30 minutes each day and reducing my cost base (while keeping my share total). I call it "the morning wood". It rises up around .15 - .30 and I sell off half my shares. It then goes flacid and drops by around .20, and I rebuy.Nice day for Cytodyn.
I feel like we have a few more of these left but gonna need to make a decision soon on how much to hold when they unblind the data.
Between the endpoint being a difficult one as more have moved away from mortality and the wildcard that is the FDA, I still want to secure some of these recent gains. Call me Mulholland.
Just don't get caught with your morning wood out and your pants downI have been playing the first 30 minutes each day and reducing my cost base (while keeping my share total). I call it "the morning wood". It rises up around .15 - .30 and I sell off half my shares. It then goes flacid and drops by around .20, and I rebuy.
When there is no news, this seems to occur on 4 of the 5 trading days in a week.
Holy Jesus. I left for the last 20 minutes of the market and damn.
power hour
I know the moment I do this will be the moment it shoots the moon.I have been playing the first 30 minutes each day and reducing my cost base (while keeping my share total). I call it "the morning wood". It rises up around .15 - .30 and I sell off half my shares. It then goes flacid and drops by around .20, and I rebuy.
When there is no news, this seems to occur on 4 of the 5 trading days in a week.
Any significant news shouldn't drop during trading hours.I know the moment I do this will be the moment it shoots the moon.
That’s today? Thought it was tomorrow?$6 sounds like a good exit point. This afternoon's CC has far more potential to tank the stock price than raise it. What good news could possibly come out of the CC?
You're right, my bad. I thought today was Jan 6th, lol. In my defense, I'm on a beach in Jamaica. I blame the skliff.That’s today? Thought it was tomorrow?
You just got an extra day of vacation, niiiiice.I thought today was Jan 6th, lol. In my defense, I'm on a beach in Jamaica.
HodorI'd sell right now. There is a 10% chance that the stock price will keep going up on Thursday and Friday and hit $5.00 before the week is through. But it going down is more likely.
I've been wrong more than once. I've been right more than I've been wrong.Enough with the I’d sell now ####
I finally bailed at 5.98....tired of watching this stock every day....
It's the daily excitement. Gives you something to do all day. Every day. For weeks. And months. And more months.why not?
::sigh::It's the daily excitement. Gives you something to do all day. Every day. For weeks. And months. And more months.
Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.why not?
Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.
Bc this is the time we’ve all been waiting for. Not saying the fda thing will happen, but if it does it will be in the next 60 days.why not?
At the rate we're going, there won't be anyone left to sue the drug in 60 days.Bc this is the time we’ve all been waiting for. Not saying the fda thing will happen, but if it does it will be in the next 60 days.
Oh Don Hutson. We love you so.Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.
This is the steaming mess shorts turn into when they fail.Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.
I'm pretty sure this is code that you are very bullish on CYDY right now.Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.
Nah...with 20 other indications and 200 countries in the world NP says we'll be fine.I'm pretty sure this is code that you are very bullish on CYDY right now.
I'm not even sure about the low risk/high reward part part though. If it looks like no approval, it will be difficult to get out fast enough.
Actually, cancer was also a big part of the initial push.Nah...with 20 other indications and 200 countries in the world NP says we'll be fine.
Really would like to see the HIV use finalized and some revenue starting. That alone was the reason @chet suggested this stock in the first place. It would be ashamed if the Civid diversion ends up burying a company with a useful product.
I think it's definitely risky to buy in at $6.00. This will drop to $3.00 pretty quick on a trial failure. If your initial buy-in is at $3.00 or less, then you are pretty safe.Leronblimblam does have a realistic chance at a EUA. And CytoNerds won't sell quickly if/when it becomes obvious that the trial was a failure. I consider owning CYDY during unblinding a low risk/high reward scenario.
At 6:00am on July 21st, CytoDyn had a press release about the SAEs of the M2M trial instead of releasing the topline results of the M2M trial. It was obvious that the trial didn't meet its primary endpoint. It was an obvious time to sell. But initially, people bought. The stock price gapped up 1 cent from July 20th's close of $6.34 to open at $6.35 on July 21st. The stock price proceeded to rise to $6.75. It then dropped to $5.07 and finished the day at $5.72. Over the next month, the stock price steadily declined ultimately bottoming out at $2.76 on August 19th.If it looks like no approval, it will be difficult to get out fast enough.
I've been thinking for months that a logjam will all of a sudden open up after the inauguration. Whether it's this one or one of the others or several of them....Don't mean to get political here, but the timing of the reveal and the new president are pretty close. Any chance Biden's people push this through if the get wind of it to post an early W in the win column? By the same token, is big Pharma embedded enough in the establishment pocket to derail leronlimab?
I’ve thought about this too, but why wouldn’t trump have wanted the W, especially if there was any indication it worked around election time?Don't mean to get political here, but the timing of the reveal and the new president are pretty close. Any chance Biden's people push this through if the get wind of it to post an early W in the win column? By the same token, is big Pharma embedded enough in the establishment pocket to derail leronlimab?
Trump placated to Big Pharma and it was easy to feed Trump only the information you wanted him to hear. Trump didn't investigate anything beyond what was on Fox News. None of them wanted to see some two-bit startup with a greasy CEO move in on their profits.I’ve thought about this too, but why wouldn’t trump have wanted the W, especially if there was any indication it worked around election time?
If he wanted a W, he wouldn't have pimped bleach and hydroxychloroquine. And that's an apolitical statement.I’ve thought about this too, but why wouldn’t trump have wanted the W, especially if there was any indication it worked around election time?
It will be a much quicker plummet this time I can just about guarantee that. They won't have anything left for Covid in their pocket At least at the point you mentioned, they still had severe critical to go. I guess there is always longhaulers but the trust will have eroded.At 6:00am on July 21st, CytoDyn had a press release about the SAEs of the M2M trial instead of releasing the topline results of the M2M trial. It was obvious that the trial didn't meet its primary endpoint. It was an obvious time to sell. But initially, people bought. The stock price gapped up 1 cent from July 20th's close of $6.34 to open at $6.35 on July 21st. The stock price proceeded to rise to $6.75. It then dropped to $5.07 and finished the day at $5.72. Over the next month, the stock price steadily declined ultimately bottoming out at $2.76 on August 19th.
Really tough call. I do think it goes up early tomorrow, but difficult to say if it drops later in the day. But we should see a strong final hour.I think it will be up tomorrow but I'm gonna start trimming in the morning. Selling a 1/3 of my shares to lock in some of the gains. If for some reason, the price drops a lot after the CC and the reason doesn't seem valid, I may purchase them back to trade again the following week. If it shoots higher, that will be good, but I won't be planning to buy them back.